C3 JIAN INC has a total of 26 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ASCLEPIX THERAPEUTICS INC, BR PHARM CO LTD and WILSON D TRAVIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Basic materials chemistry | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Eckert Randal H | 25 |
#2 | He Jian | 15 |
#3 | Yarbrough Daniel K | 15 |
#4 | Anderson Maxwell | 13 |
#5 | Kaplan Chris | 12 |
#6 | Sim Jee-Hyun | 12 |
#7 | Varnum Brian C | 8 |
#8 | Kaplan Christopher W | 6 |
#9 | Kyme Pierre A | 6 |
#10 | Shi Wenyuan | 4 |
Publication | Filing date | Title |
---|---|---|
AU2016228293A1 | Selectively targeted antimicrobial peptides and the use thereof | |
US2016207969A1 | Clostridium difficile targeting moieties and constructs comprising said moieties | |
EP3166959A1 | Targeting peptides that bind s. mutans, constructs comprising such peptides and uses thereof | |
US2014314691A1 | Compositions for improving the appearance and/or health of teeth | |
WO2010080819A1 | Targeted antimicrobial moieties |